SCHEMBL5257441

SCHEMBL5257441

COc1cc2nc(-c3ccc(C(F)(F)F)cc3)nc(O)c2cc1OC

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
WHR1 P49842 1/20 0.49
TDO2 P48775 2/20 0.47
IDO1 P14902 1/20 0.47
ABCG2 Q9UNQ0 3/20 0.43
KDR P35968 2/20 0.43
SLC2A1 P11166 1/20 0.43
KDM4E B2RXH2 1/20 0.43
STAT6 P42226 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
PDE3B Q13370 1/20 0.42
PDE3A Q14432 1/20 0.42
PDE10A Q9Y233 1/20 0.42
MAPK7 Q13164 1/20 0.41
ADRA1D P25100 1/20 0.41
ADRA1A P35348 1/20 0.41
ADRA1B P35368 1/20 0.41
PDGFRB P09619 2/20 0.40
PDGFRA P16234 2/20 0.40
TP53 P04637 1/20 0.40
NTSR1 P30989 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24393307 0.85 WHR1 (0.50) WHR1TDO2IDO1ABCG2KDR
SCHEMBL5261050 0.84 WHR1 (0.49) WHR1TDO2IDO1ABCG2KDR
SCHEMBL5257184 0.83 WHR1 (0.54) WHR1ABCG2SLC2A1KDM4ESTAT6
SCHEMBL3459996 0.83 WHR1 (0.54) WHR1ABCG2KDM4ESTAT6NPSR1
SCHEMBL5258730 0.82 WHR1 (0.52) WHR1KDRKDM4ESTAT6NPSR1
SCHEMBL24391550 0.82 WHR1 (0.47) WHR1TDO2IDO1ABCG2KDR
SCHEMBL7267818 0.79 HTT (0.58) WHR1ABCG2KDRSLC2A1KDM4E
SCHEMBL7262625 0.77 KDM4E (0.60) WHR1KDM4ESTAT6NPSR1NTSR1
SCHEMBL7262023 0.77 KDM4E (0.54) SLC2A1KDM4ESTAT6NPSR1PDGFRB
SCHEMBL16037770 0.76 WHR1 (0.48) WHR1KDM4ESTAT6NPSR1PDE3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1040101-B1 SUBSTITUTED 2-ARYL-4-AMINO-CHINAZOLINES, METHOD FOR THE PRODUCTION AND USE THEREOF AS MEDICAMENTS SANOFI AVENTIS DEUTSCHLAND (DE) 2007-04-25 EP disclosed
US-6613772-B1 Drugs such as 2-(p-chlorophenyl-4-(4-hydroxybutyl)amino-6,7,8 -trimethoxyquinazoline used for activation of guanylate cyclase and modulation of cyclic guanosine monophosphate AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2003-09-02 US disclosed
EP-1040101-A1 SUBSTITUTED 2-ARYL-4-AMINO-CHINAZOLINES, METHOD FOR THE PRODUCTION AND USE THEREOF AS MEDICAMENTS Aventis Pharma Deutschland GmbH (DE) 2000-10-04 EP disclosed
WO-1999032460-A1 SUBSTITUTED 2-ARYL-4-AMINO-CHINAZOLINES, METHOD FOR THE PRODUCTION AND USE THEREOF AS MEDICAMENTS AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 1999-07-01 WO disclosed